Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
15,966 | Dovepress* | 14,873+ | 1,611 | 16,484 | |
PubMed Central* | 1,093 | 355 | 1,448 | ||
Totals | 15,966 | 1,966 | 17,932 | ||
*Since 26 July 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar